Newamsterdam Pharma Company Nv (NAMS)

Jul 17, 2025

Goldman Sachs Initiates Coverage on NewAmsterdam Pharma With Neutral Rating, $27 Price Target - MarketScreener

Jul 17, 2025

Jul 17, 2025

Goldman Sachs initiates NewAmsterdam Pharma stock with Neutral rating By Investing.com - Investing.com Nigeria

Jul 17, 2025

Jul 17, 2025

Goldman Sachs initiates NewAmsterdam Pharma stock with Neutral rating - Investing.com

Jul 17, 2025

Jul 17, 2025

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives $42.89 Consensus Price Target from Analysts - Defense World

Jul 17, 2025

Jul 16, 2025

Jefferies Remains Bullish on NewAmsterdam Pharma (NAMS) - MSN

Jul 16, 2025

Jul 16, 2025

12 Oversold NASDAQ Stocks to Buy Now - Insider Monkey

Jul 16, 2025

Jul 16, 2025

Why NewAmsterdam Pharma Company N.V. Equity Warrant stock attracts strong analyst attentionWatchlist Winner Update - Newser

Jul 16, 2025

Jul 15, 2025

Why NewAmsterdam Pharma Company N.V. stock attracts strong analyst attentionFree Step-by-Step Investment Guide - Newser

Jul 15, 2025

Jul 15, 2025

What makes NewAmsterdam Pharma Company N.V. stock price move sharplyFree Stock Market Insider Analysis - Newser

Jul 15, 2025

Jul 15, 2025

How NewAmsterdam Pharma Company N.V. stock performs during market volatilityFree Stock Market Knowledge Sharing - Newser

Jul 15, 2025

Jul 15, 2025

What makes NewAmsterdam Pharma Company N.V. Equity Warrant stock price move sharplyAlpha Stock Ideas - Newser

Jul 15, 2025

Jul 11, 2025

NewAmsterdam Pharma updates employment agreement with chief scientific officer By Investing.com - Investing.com India

Jul 11, 2025

Jul 11, 2025

NewAmsterdam Pharma updates employment agreement with chief scientific officer - Investing.com

Jul 11, 2025

Jul 07, 2025

Mirae Asset Global Investments Co. Ltd. Purchases 596 Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) - Defense World

Jul 07, 2025

Jul 05, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Stock Rating Upgraded by Wall Street Zen - Defense World

Jul 05, 2025

Jun 27, 2025

Thursday’s Insider Moves: Big Buys at NewAmsterdam Pharma, CME Group - Investing.com Australia

Jun 27, 2025

Jun 26, 2025

NAMSW SEC FilingsNewAmsterdam Pha 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 26, 2025

Jun 18, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Now Covered by Citigroup - Defense World

Jun 18, 2025

Jun 18, 2025

Citi initiates NewAmsterdam Pharma stock with buy rating on cholesterol drug - Investing.com Nigeria

Jun 18, 2025

Jun 17, 2025

Citi initiates NewAmsterdam Pharma stock with buy rating on cholesterol drug By Investing.com - Investing.com South Africa

Jun 17, 2025

Jun 17, 2025

Citi Recommends NewAmsterdam Pharma (NAMS) with a Strong Outlook | NAMS Stock News - GuruFocus

Jun 17, 2025

Jun 15, 2025

How the (NAMS) price action is used to our Advantage - news.stocktradersdaily.com

Jun 15, 2025

Jun 14, 2025

Stifel initiates NewAmsterdam stock with Buy rating, $44 target By Investing.com - Investing.com Nigeria

Jun 14, 2025

Jun 14, 2025

NewAmsterdam Pharma’s SWOT analysis: stock poised for cardiovascular breakthrough By Investing.com - Investing.com India

Jun 14, 2025

Jun 13, 2025

NewAmsterdam Pharma’s SWOT analysis: stock poised for cardiovascular breakthrough - Investing.com

Jun 13, 2025

Jun 13, 2025

NewAmsterdam Pharma’s (NAMS) “Buy” Rating Reaffirmed at Needham & Company LLC - Defense World

Jun 13, 2025

Jun 13, 2025

NAMS: Needham Reiterates Buy Rating and Maintains Price Target | - GuruFocus

Jun 13, 2025

Jun 12, 2025

Cantor Fitzgerald maintains NewAmsterdam Pharma stock rating on trial data By Investing.com - Investing.com India

Jun 12, 2025

Jun 12, 2025

NewAmsterdam Pharma stock maintains buy rating at Stifel on strong data - Investing.com Nigeria

Jun 12, 2025

Jun 12, 2025

Cantor Fitzgerald maintains NewAmsterdam Pharma stock rating on trial data - Investing.com

Jun 12, 2025

Jun 12, 2025

California State Teachers Retirement System Raises Position in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Jun 12, 2025

Jun 11, 2025

13 Biotech Stocks with Huge Upside Potential - Insider Monkey

Jun 11, 2025

Jun 11, 2025

NewAmsterdam Pharma Company N.V. (NAMS) Initiated with a Buy at Stifel - Insider Monkey

Jun 11, 2025

Jun 11, 2025

Transcript : NewAmsterdam Pharma Company N.V.Special Call - MarketScreener

Jun 11, 2025

Jun 11, 2025

Frazier Lifesciences Acquisition : NewAmsterdam Pharma R&D Day 2025 - MarketScreener

Jun 11, 2025

Jun 11, 2025

NewAmsterdam Pharma Schedules R&D Day for June 2025 - TipRanks

Jun 11, 2025

Jun 11, 2025

Brokers Set Expectations for NAMS FY2026 Earnings - Defense World

Jun 11, 2025

Jun 11, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Coverage Initiated by Analysts at Stifel Nicolaus - Defense World

Jun 11, 2025

Jun 11, 2025

Kalkine: NewAmsterdam Pharma Progress in Nasdaq Index Spotlight Event - Kalkine Media

Jun 11, 2025

Jun 11, 2025

(NAMSW) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 11, 2025

Jun 10, 2025

NewAmsterdam Pharma (NAMS): Stifel Initiates Coverage with Buy Rating | NAMS Stock News - GuruFocus

Jun 10, 2025

Jun 10, 2025

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Analysts Just Trimmed Their Revenue Forecasts By 14% - simplywall.st

Jun 10, 2025

Jun 10, 2025

Analysts Have Just Cut Their NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Revenue Estimates By 14% - Yahoo Finance

Jun 10, 2025